Shah Sanjiv J, Thenappan Thenappan, Rich Stuart, Tian Lu, Archer Stephen L, Gomberg-Maitland Mardi
Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill 60637, USA.
Circulation. 2008 May 13;117(19):2475-83. doi: 10.1161/CIRCULATIONAHA.107.719500. Epub 2008 May 5.
Renal dysfunction predicts mortality in patients with cardiovascular disease. How renal dysfunction relates to hemodynamics and mortality in pulmonary arterial hypertension (PAH) remains unclear.
We performed a cohort study of 500 patients with World Health Organization group I PAH from 1982 to 2006 with data on demographics, comorbidities, medications, functional class, laboratory tests, exercise testing results, and hemodynamics. Serum creatinine (SCr) was determined on entry into the study (initial PAH clinic visit). Vital status was determined from hospital records and the Social Security Death Index. We used a Cox proportional hazards analysis to determine whether SCr was an independent predictor of mortality. Mean age on entry into the study was 48+/-14 years, and 79% of subjects were female. Mean SCr was 1.05+/-0.35 mg/dL. Elevated SCr was associated with higher right atrial pressure and lower cardiac index. During a median follow-up of 3.5 years, 279 deaths (55.8% of the cohort) occurred. Compared with patients with SCr <1.0 mg/dL, those with SCr 1.0 to 1.4 mg/dL and SCr >1.4 mg/dL had an increased hazard ratio of death (unadjusted hazard ratio 1.65, 95% confidence interval 1.26 to 2.17, P<0.0001 for SCr 1.0 to 1.4 mg/dL; unadjusted hazard ratio 2.54, 95% confidence interval 1.73 to 3.71, P<0.0001 for SCr >1.4 mg/dL). On multivariable analysis, we found a significant interaction between SCr and right atrial pressures (interaction P<0.0001); increased SCr best predicted death in patients with right atrial pressure <10 mm Hg.
Renal dysfunction is associated with a worse hemodynamic profile and is an independent predictor of mortality in PAH. Measurement of SCr is practical and offers a simple way to noninvasively predict outcome.
肾功能不全可预测心血管疾病患者的死亡率。肾功能不全与肺动脉高压(PAH)患者的血流动力学及死亡率之间的关系尚不清楚。
我们对1982年至2006年间500例世界卫生组织I组PAH患者进行了一项队列研究,收集了人口统计学、合并症、用药情况、功能分级、实验室检查、运动试验结果及血流动力学数据。在研究开始时(首次PAH门诊就诊)测定血清肌酐(SCr)。通过医院记录和社会保障死亡指数确定生存状态。我们使用Cox比例风险分析来确定SCr是否为死亡率的独立预测因素。研究开始时的平均年龄为48±14岁,79%的受试者为女性。平均SCr为1.05±0.35mg/dL。SCr升高与较高的右心房压力和较低的心指数相关。在中位随访3.5年期间,发生279例死亡(占队列的55.8%)。与SCr<1.0mg/dL的患者相比,SCr为1.0至1.4mg/dL和SCr>1.4mg/dL的患者死亡风险比增加(未调整的风险比1.65,95%置信区间1.26至2.17,SCr为1.0至1.4mg/dL时P<0.0001;未调整的风险比2.54,95%置信区间1.73至3.71,SCr>1.4mg/dL时P<0.0001)。多变量分析时,我们发现SCr与右心房压力之间存在显著交互作用(交互作用P<0.0001);SCr升高最能预测右心房压力<10mmHg患者的死亡。
肾功能不全与更差的血流动力学特征相关,是PAH患者死亡率的独立预测因素。测定SCr切实可行,提供了一种无创预测预后的简单方法。